These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

325 related items for PubMed ID: 10668342

  • 21. Polymorphisms of the vascular endothelial growth factor and susceptibility to diabetic microvascular complications in patients with type 1 diabetes mellitus.
    Yang B, Cross DF, Ollerenshaw M, Millward BA, Demaine AG.
    J Diabetes Complications; 2003; 17(1):1-6. PubMed ID: 12505748
    [Abstract] [Full Text] [Related]

  • 22. Novel Genetic Actors of Diabetes-Associated Microvascular Complications: Retinopathy, Kidney Disease and Neuropathy.
    Davoudi S, Sobrin L.
    Rev Diabet Stud; 2015; 12(3-4):243-59. PubMed ID: 26859656
    [Abstract] [Full Text] [Related]

  • 23. Complications of Diabetes 2016.
    Papatheodorou K, Papanas N, Banach M, Papazoglou D, Edmonds M.
    J Diabetes Res; 2016; 2016():6989453. PubMed ID: 27822482
    [No Abstract] [Full Text] [Related]

  • 24. Paraoxonase gene cluster is a genetic marker for early microvascular complications in type 1 diabetes.
    Kao Y, Donaghue KC, Chan A, Bennetts BH, Knight J, Silink M.
    Diabet Med; 2002 Mar; 19(3):212-5. PubMed ID: 11918623
    [Abstract] [Full Text] [Related]

  • 25. The FTO variant is associated with chronic complications of diabetes mellitus in Czech population.
    Hubacek JA, Dlouha D, Klementova M, Lanska V, Neskudla T, Pelikanova T.
    Gene; 2018 Feb 05; 642():220-224. PubMed ID: 29154870
    [Abstract] [Full Text] [Related]

  • 26. [Polymorphism of aldose reductase gene and susceptibility to retinopathy and nephropathy in Caucasians with type 1 diabetes].
    Fanelli A, Hadjadj S, Gallois Y, Fumeron F, Betoule D, Grandchamp B, Marre M.
    Arch Mal Coeur Vaiss; 2002 Feb 05; 95(7-8):701-8. PubMed ID: 12365083
    [Abstract] [Full Text] [Related]

  • 27. The DG10S478 variant in the TCF7L2 gene is not associated with microvascular complications in type 2 diabetes.
    Buchbinder S, Rudofsky G, Humpert PM, Schilling T, Zorn M, Bierhaus A, Nawroth PP.
    Exp Clin Endocrinol Diabetes; 2008 Apr 05; 116(4):211-4. PubMed ID: 18072015
    [Abstract] [Full Text] [Related]

  • 28. Contribution of gene polymorphisms in the renin-angiotensin system to macroangiopathy in patients with diabetic nephropathy.
    Wong TY, Szeto CC, Chow KM, Chan JC, Li PK.
    Am J Kidney Dis; 2001 Jul 05; 38(1):9-17. PubMed ID: 11431175
    [Abstract] [Full Text] [Related]

  • 29. Diabetic peripheral neuropathy: effects of age, duration of diabetes, glycemic control, and vascular factors.
    Valensi P, Giroux C, Seeboth-Ghalayini B, Attali JR.
    J Diabetes Complications; 1997 Jul 05; 11(1):27-34. PubMed ID: 9025010
    [Abstract] [Full Text] [Related]

  • 30. Genetics of diabetes mellitus and diabetes complications.
    Cole JB, Florez JC.
    Nat Rev Nephrol; 2020 Jul 05; 16(7):377-390. PubMed ID: 32398868
    [Abstract] [Full Text] [Related]

  • 31. Long-term complications of diabetes mellitus, Part I: Retinopathy, nephropathy, neuropathy.
    Muñana KR.
    Vet Clin North Am Small Anim Pract; 1995 May 05; 25(3):715-30. PubMed ID: 7660543
    [Abstract] [Full Text] [Related]

  • 32. Aldose reductase gene polymorphism is associated with progression of diabetic nephropathy in Japanese patients with type 1 diabetes mellitus.
    Yamamoto T, Sato T, Hosoi M, Yoshioka K, Tanaka S, Tahara H, Nishizawa Y, Fujii S.
    Diabetes Obes Metab; 2003 Jan 05; 5(1):51-7. PubMed ID: 12542725
    [Abstract] [Full Text] [Related]

  • 33. A M55V polymorphism in the SUMO4 gene is associated with a reduced prevalence of diabetic retinopathy in patients with Type 1 diabetes.
    Rudofsky G, Schlotterer A, Humpert PM, Tafel J, Morcos M, Nawroth PP, Bierhaus A, Hamann A.
    Exp Clin Endocrinol Diabetes; 2008 Jan 05; 116(1):14-7. PubMed ID: 17926234
    [Abstract] [Full Text] [Related]

  • 34. The 20210 G to A prothrombin polymorphism and late complications in type 1 diabetes mellitus.
    Humpert PM, Isermann B, Rudofsky G, Ziegler R, Bierhaus A, Ritz E, Nawroth PP.
    Thromb Haemost; 1999 Jan 05; 81(1):164. PubMed ID: 10348712
    [No Abstract] [Full Text] [Related]

  • 35. Prevention of microvascular complications in diabetic children and adolescents.
    Verrotti A, Catino M, Di Ricco L, Casani A, Chiarelli F.
    Acta Paediatr Suppl; 1999 Jan 05; 88(427):35-8. PubMed ID: 10195852
    [Abstract] [Full Text] [Related]

  • 36. [Polymorphism of the dinucleotide repeat inside the aldose reductase gene in normal states and in patients with insulin-dependent diabetes mellitus with vascular complications].
    Chistiakov DA, Turakulov RI, Girashko NM, Demurov LM, Rachiba IuM, Kondrat'ev IaIu, Milen'kaia TM, Shestakova MV, Dedov II, Nosikov VV.
    Mol Biol (Mosk); 1997 Jan 05; 31(5):778-83. PubMed ID: 9454059
    [No Abstract] [Full Text] [Related]

  • 37. Aldose reductase inhibitors and diabetic complications.
    Tomlinson DR, Willars GB, Carrington AL.
    Pharmacol Ther; 1992 Jan 05; 54(2):151-94. PubMed ID: 1438531
    [Abstract] [Full Text] [Related]

  • 38. Polymorphisms of the aldose reductase locus (ALR2) and susceptibility to diabetic microvascular complications.
    Patel A, Ratanachaiyavong S, Millward BA, Demaine AG.
    Adv Exp Med Biol; 1993 Jan 05; 328():325-32. PubMed ID: 8493909
    [No Abstract] [Full Text] [Related]

  • 39. The role of protein kinase C activation and the vascular complications of diabetes.
    Das Evcimen N, King GL.
    Pharmacol Res; 2007 Jun 05; 55(6):498-510. PubMed ID: 17574431
    [Abstract] [Full Text] [Related]

  • 40. [Can late sequelae of diabetes be avoided? Various critical observations].
    Ganz K.
    Schweiz Rundsch Med Prax; 1994 Jan 18; 83(3):72-4. PubMed ID: 8296133
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.